Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer : a Multicentre, Single Arm, Phase 2 Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07104149
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:29.838337+00:00
Published At
2025-08-05T00:00:00+00:00
Record Updated At
2025-08-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Female, Age \u2265 18 Years Old", "No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy", "ECOG Score of 0-1", "Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion", "Sufficient Organ Function", "The Result of the Urine or Serum Pregnancy Test for the Subject is Negative", "Subjects Should Take Contraceptive Measures", "Locally Advanced Cervical Cancer", "Expected Survival Time \u0026gt;6 Months"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-05"
protocolSection.identificationModule.nctId
"NCT07104149"
protocolSection.identificationModule.officialTitle
"Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer : a Multicentre, Single Arm, Phase 2 Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Female, Age ≥ 18 Years Old (protocolSection.conditionsModule.conditions)
  • No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy (protocolSection.conditionsModule.conditions)
  • ECOG Score of 0-1 (protocolSection.conditionsModule.conditions)
  • Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion (protocolSection.conditionsModule.conditions)
  • Sufficient Organ Function (protocolSection.conditionsModule.conditions)
  • The Result of the Urine or Serum Pregnancy Test for the Subject is Negative (protocolSection.conditionsModule.conditions)
  • Subjects Should Take Contraceptive Measures (protocolSection.conditionsModule.conditions)
  • Locally Advanced Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Expected Survival Time >6 Months (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.